Marta Torres‐Ferrús

1.9k total citations
58 papers, 1.0k citations indexed

About

Marta Torres‐Ferrús is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Marta Torres‐Ferrús has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Psychiatry and Mental health, 35 papers in Pathology and Forensic Medicine and 11 papers in Physiology. Recurrent topics in Marta Torres‐Ferrús's work include Migraine and Headache Studies (50 papers), Trigeminal Neuralgia and Treatments (34 papers) and Psychosomatic Disorders and Their Treatments (10 papers). Marta Torres‐Ferrús is often cited by papers focused on Migraine and Headache Studies (50 papers), Trigeminal Neuralgia and Treatments (34 papers) and Psychosomatic Disorders and Their Treatments (10 papers). Marta Torres‐Ferrús collaborates with scholars based in Spain, Palestinian Territory and Colombia. Marta Torres‐Ferrús's co-authors include Patricia Pozo‐Rosich, Alicia Alpuente, Victor J Gallardo, Edoardo Caronna, Manuel Quintana, José Álvarez‐Sabín, Jessica Fernández‐Morales, Sofía Lallana, Alfons Macaya and Juan Luis Restrepo‐Vera and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Journal of Neurology.

In The Last Decade

Marta Torres‐Ferrús

56 papers receiving 1.0k citations

Peers

Marta Torres‐Ferrús
Marta Torres‐Ferrús
Citations per year, relative to Marta Torres‐Ferrús Marta Torres‐Ferrús (= 1×) peers Victor J Gallardo

Countries citing papers authored by Marta Torres‐Ferrús

Since Specialization
Citations

This map shows the geographic impact of Marta Torres‐Ferrús's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Torres‐Ferrús with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Torres‐Ferrús more than expected).

Fields of papers citing papers by Marta Torres‐Ferrús

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Torres‐Ferrús. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Torres‐Ferrús. The network helps show where Marta Torres‐Ferrús may publish in the future.

Co-authorship network of co-authors of Marta Torres‐Ferrús

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Torres‐Ferrús. A scholar is included among the top collaborators of Marta Torres‐Ferrús based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Torres‐Ferrús. Marta Torres‐Ferrús is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López-Bravo, A., Ane Mínguez‐Olaondo, Alicia Alpuente, et al.. (2025). Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study. Headache The Journal of Head and Face Pain. 65(6). 994–1004. 2 indexed citations
2.
Caronna, Edoardo, et al.. (2025). Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days. Cephalalgia. 45(4). 2235377575–2235377575. 1 indexed citations
3.
Alpuente, Alicia, Marta Torres‐Ferrús, Edoardo Caronna, & Patricia Pozo‐Rosich. (2024). The state of art on the use of patient reported outcomes in migraine. Current Opinion in Neurology. 37(3). 271–282. 2 indexed citations
4.
Caronna, Edoardo, et al.. (2024). Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population. The Journal of Headache and Pain. 25(1). 21–21. 8 indexed citations
5.
Caronna, Edoardo, Alicia Alpuente, Marta Torres‐Ferrús, & Patricia Pozo‐Rosich. (2024). CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention. Handbook of clinical neurology. 199. 107–124. 14 indexed citations
6.
Belvís, R., Pablo Irimia, Marta Torres‐Ferrús, et al.. (2023). Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology’s Headache Study Group. SHILAP Revista de lepidopterología. 38(9). 635–646. 4 indexed citations
7.
Torres‐Ferrús, Marta, Vicente González‐Quintanilla, N. González-García, et al.. (2023). The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients. Neurología (English Edition). 38(8). 541–549. 1 indexed citations
8.
Alpuente, Alicia, et al.. (2021). Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks. Cephalalgia. 42(3). 186–196. 49 indexed citations
9.
Torres‐Ferrús, Marta, Vicente González‐Quintanilla, N. González-García, et al.. (2021). The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients. Neurología. 38(8). 541–549. 3 indexed citations
10.
Alpuente, Alicia, Victor J Gallardo, Edoardo Caronna, Marta Torres‐Ferrús, & Patricia Pozo‐Rosich. (2021). In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study. The Journal of Headache and Pain. 22(1). 151–151. 24 indexed citations
11.
Латышева, Н. В., Marta Torres‐Ferrús, Simona Sacco, et al.. (2021). InterMiG: international differences in the therapeutic approach to migraine patients in specialized headache centers. The Journal of Headache and Pain. 22(1). 43–43. 2 indexed citations
12.
Caronna, Edoardo, Victor J Gallardo, Alicia Alpuente, Marta Torres‐Ferrús, & Patricia Pozo‐Rosich. (2021). Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability. Journal of Neurology. 269(3). 1456–1462. 10 indexed citations
13.
Caronna, Edoardo, Victor J Gallardo, Alicia Alpuente, Marta Torres‐Ferrús, & Patricia Pozo‐Rosich. (2021). Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months. The Journal of Headache and Pain. 22(1). 120–120. 62 indexed citations
14.
Caronna, Edoardo, Victor J Gallardo, Alicia Alpuente, et al.. (2021). Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications. Neurología. 36(8). 611–617. 19 indexed citations
15.
Torres‐Ferrús, Marta, et al.. (2021). The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study. Journal of Neurology. 268(10). 3789–3798. 64 indexed citations
16.
Gallardo, Victor J, Alicia Alpuente, Marta Torres‐Ferrús, et al.. (2021). The impact of a digital platform on migraine patient‐centered outcome research. Evaluation of midolordecabeza.org , a headache website in Spanish. Headache The Journal of Head and Face Pain. 61(9). 1403–1410. 2 indexed citations
17.
Torres‐Ferrús, Marta, Victor J Gallardo, Alicia Alpuente, & Patricia Pozo‐Rosich. (2020). Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA. The Journal of Headache and Pain. 21(1). 88–88. 26 indexed citations
18.
Torres‐Ferrús, Marta, Alicia Alpuente, & Patricia Pozo‐Rosich. (2019). How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspective. Current Opinion in Neurology. 32(3). 395–404. 13 indexed citations
19.
Gago‐Veiga, Ana Beatriz, David García‐Azorín, Vicente González‐Quintanilla, et al.. (2019). ¿Qué preguntar, cómo explorar y qué escalas usar en el paciente con cefalea? Recomendaciones del Grupo de Estudio de Cefalea de la Sociedad Española de Neurología. Neurología. 37(7). 564–574. 3 indexed citations
20.
Leira, Yago, Patricia Pozo‐Rosich, Marta Torres‐Ferrús, et al.. (2019). Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain. Odontology. 107(4). 530–535. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026